unknown
Stage
2020
Founded
1
Investors
About
ArsenalBio develops cell programming technology to engineer custom cellular therapies for treating cancer and other diseases by reprogramming cells with synthetic biology.
Explore ArsenalBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.